Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
- 1 July 1996
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (2) , 273-280
- https://doi.org/10.1016/0006-2952(96)00204-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Direct Evidence That Perhexiline Modifies Myocardial Substrate Utilization from Fatty Acids to LactateJournal of Cardiovascular Pharmacology, 1995
- Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Evidence for malonyl-CoA-sensitive carnitine acyl-CoA transferase activity in sarcoplasmic reticulum of canine heartJournal of Molecular and Cellular Cardiology, 1992
- Pharmacology and Pharmacokinetics of AmiodaroneThe Journal of Clinical Pharmacology, 1991
- Perhexiline maleate treatment for severe angina pectoris — correlations with pharmacokineticsInternational Journal of Cardiology, 1986
- Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyl oxirane carboxylate (B 807‐27) due to inhibition of CPT I (EC 2.3.1.21)European Journal of Biochemistry, 1985
- Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardiaAmerican Heart Journal, 1983
- Cardiac β-adrenoceptor modulation by amiodaroneBiochemical Pharmacology, 1983
- Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heartLife Sciences, 1980
- Effects of Perhexiline on Coronary Hemodynamic and Myocardial Metabolic Responses to TachycardiaCirculation, 1974